Literature DB >> 8187332

Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.

P T Soboslay1, C G Lüder, W H Hoffmann, I Michaelis, G Helling, C Heuschkel, C M Dreweck, C H Blanke, S Pritze, M Banla.   

Abstract

The present study examined the quantitative and qualitative changes registered in the parasite-specific antibody response, cellular reactivity and cytokine production profile in onchocerciasis patients repeatedly treated with ivermectin over a period of 8 years. The densities of Onchocerca volvulus microfilariae (mf) in treated patients remained significantly reduced, whereas the number of permanently amicrofilaridermic patients (subclinical infection) increased with repeated treatments. In vitro cellular responses to O. volvulus antigen (OvAg) were highest (P < 0.01) in untreated control individuals exposed to infection, but negative for mf of O. volvulus (endemic normals). Cellular reactivity in repeatedly treated patients was higher at 84 than at 36 months post initial treatment (p.i.t); furthermore, the proliferative responses to OvAg, mycobacterial purified protein derivative (PPD) and streptococcal SL-O were greater (P < 0.05) at 84 months p.i.t. in amicrofilaridermic than in microfilaria-positive onchocerciasis patients. In amicrofilaridermic patients such reactivity approached the magnitude observed in endemic normals. Peripheral blood mononuclear cells (PBMC) from patients and endemic normals produced equivalent amounts of IL-2, IL-4 and interferon-gamma (IFN-gamma) in response to mitogenic stimulation with phytohaemagglutinin (PHA); in response to OvAg, however, significantly more IL-2 and IFN-gamma were produced by PBMC from subclinical amicrofilaridermic patients or endemic normals than by mf-positive patients. OvAg-specific production of IL-4 by PBMC from treated patients was lower at 84 than at 36 months p.i.t. At three months p.i.t. the titres of circulating OvAg-specific IgG1-3 had increased (P < 0.05), but they then continuously declined with repeated treatments. Only IgG1 and IgG4 bound to OvAg of mol. wt 2-12 kD at 1 month p.i.t., while recognition of OvAg of mol. wt 10-200 kD by IgG1, IgG2 and IgG4 reached a maximum intensity at 3-6 months p.i.t., with the overall intensity of binding to OvAg gradually weakening thereafter. These results suggest that onchocerciasis-associated immunosuppression is reversible following ivermectin-induced permanent clearance of microfilariae from the skin; and that a vigorous parasite-specific cellular reactivity and a sustained production of IL-2 and IFN-gamma in amicrofilaridermic individuals may contribute to controlling O. volvulus infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187332      PMCID: PMC1534906          DOI: 10.1111/j.1365-2249.1994.tb06548.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Cytokines: making the right choice.

Authors:  F D Finkelman; J F Urban
Journal:  Parasitol Today       Date:  1992-09

2.  Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis.

Authors:  C Steel; A Lujan-Trangay; C Gonzalez-Peralta; G Zea-Flores; T B Nutman
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

3.  Effect of ivermectin on the vertical distribution of Onchocerca volvulus microfilariae in the skin.

Authors:  S Jürgens; H Schulz-Key
Journal:  Trop Med Parasitol       Date:  1990-06

4.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

5.  Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.

Authors:  C G Lüder; P T Soboslay; A M Prince; B M Greene; R Lucius; H Schulz-Key
Journal:  Parasitology       Date:  1993-07       Impact factor: 3.234

6.  The endemic normal in lymphatic filariasis: A static concept.

Authors:  K P Day
Journal:  Parasitol Today       Date:  1991-12

7.  Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man.

Authors:  B M Greene; M M Fanning; J J Ellner
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

Review 8.  Regulation and biological function of helminth-induced cytokine responses.

Authors:  F D Finkelman; E J Pearce; J F Urban; A Sher
Journal:  Immunol Today       Date:  1991-03

9.  Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area.

Authors:  D O Freedman; T B Nutman; E A Ottesen
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

10.  Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.

Authors:  D J Ward; T B Nutman; G Zea-Flores; C Portocarrero; A Lujan; E A Ottesen
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

View more
  23 in total

1.  Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.

Authors:  Thomas S Churcher; Sébastien D S Pion; Mike Y Osei-Atweneboana; Roger K Prichard; Kwablah Awadzi; Michel Boussinesq; Richard C Collins; James A Whitworth; María-Gloria Basáñez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

2.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

3.  Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.

Authors:  C H Little; G M Georgiou; A Marceglia; H Ogedgebe; R E Cone; D Mazza
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

5.  Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice.

Authors:  S G Folkard; M J Taylor; G A Butcher; A E Bianco
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Interleukin-4 is essential for the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis.

Authors:  L Volkmann; M Saeftel; O Bain; K Fischer; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.

Authors:  P T Soboslay; C G Lüder; S Riesch; S M Geiger; M Banla; E Batchassi; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

8.  Applied field research for comprehensive helminth infection control.

Authors:  Peter T Soboslay; Richard G Gantin; Méba Banla; Potochoziou K Karabou; Abram Agossou; John K Douti; Gnansa Djassoa; Christoph Heuschkel; Hartwig Schulz-Key; David M Hamm; Peter Stingl
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

9.  Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.

Authors:  P T Soboslay; S M Geiger; B Drabner; M Banla; E Batchassi; L A Kowu; A Stadler; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

10.  Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

Authors:  A Kalinkovich; Z Weisman; Z Greenberg; J Nahmias; S Eitan; M Stein; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.